Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Dermatitis : Contact, Atopic, Occupational, Drug|January 28, 2022
Cutaneous Comorbidities Associated With Atopic Dermatitis in Israel: A Retrospective Real-World Data AnalysisYael A Leshem, Philip B Sugerman, Clara Weil, et al.
Advances in Therapy|March 30, 2022
Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider DatabaseClara Weil, Philip B Sugerman, Gabriel Chodick, et al.
International Journal of Dermatology|April 10, 2022
Facial demodicosis in the immunosuppressed state: a retrospective case series from a tertiary referral centerIris Amitay-Laish, Efrat Solomon-Cohen, Hana Feuerman, et al.
The British Journal of Dermatology|August 7, 2023
The Harmonising Outcome Measures for Eczema (HOME) implementation roadmapYael A Leshem, Eric L Simpson, Christian Apfelbacher, et al.
JAMA Dermatology|October 12, 2022
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) InitiativeYael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
The British Journal of Dermatology|December 20, 2023
How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users' guideKim S Thomas, Laura Howells, Yael A Leshem, et al.
Journal of the American Academy of Dermatology|January 12, 2020
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiativeYael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
JAMA Dermatology|May 22, 2024
Measuring Signs of Atopic Dermatitis in Clinical Practice: A HOME-CP Consensus StatementMichael E Jacobson, Yael A Leshem, Christian Apfelbacher, et al.
The Journal of Allergy and Clinical Immunology|March 30, 2022
The HOME Core outcome set for clinical trials of atopic dermatitisHywel C Williams, Jochen Schmitt, Kim S Thomas, et al.
Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.
Pageof 4